National Health Commission: chronic diseases are not absolute taboos for novel coronavirus's vaccination

Zheng Zhongwei, head of the vaccine research and development special group of the Joint Prevention and Control Mechanism of the State Council, said that according to the adverse reactions of more than 3.4 billion doses and more than 1.3 billion people who have been vaccinated in China by the Chinese Center for Disease Control and Prevention, the incidence of adverse reactions of novel coronavirus vaccine in China is similar to that of some other vaccines we have received all the year round, and the incidence of adverse reactions in the elderly is slightly lower than that in the young. Chronic diseases are not absolute taboos for novel coronavirus vaccination. They can all be vaccinated against novel coronavirus. In the plan to speed up the vaccination of novel coronavirus for the elderly, four situations that cannot be vaccinated or postponed have been identified: when the elderly have had a serious allergic reaction to the vaccine in the past, they cannot be vaccinated against novel coronavirus. Because infectious diseases are in a period of acute fever, it is recommended to postpone vaccination against novel coronavirus at this stage, for example, cancer patients are during chemotherapy, or hypertensive patients are in a hypertensive crisis.

Source: CCTV news client

Zheng Zhongwei, head of the vaccine research and development task group of the Joint Prevention and Control Mechanism of the State Council, said on December 7 that according to the monitoring of the adverse reactions of more than 3.4 billion doses and more than 1.3 billion people vaccinated by the Chinese Center for Disease Control and Prevention, the incidence of adverse reactions of novel coronavirus vaccine in China is similar to that of some other vaccines we have been vaccinated all the year round, and the incidence of adverse reactions in the elderly is slightly lower than that in the young.

Zheng Zhongwei said that chronic diseases are not absolute taboos for novel coronavirus vaccination. As long as these chronic diseases are well controlled and are in a stable stage, they can be vaccinated against novel coronavirus. In the plan to speed up the vaccination of novel coronavirus for the elderly, four situations in which vaccination cannot be or are suspended have been identified:

First, when the elderly have had serious allergic reactions when they have been vaccinated in the past, such as anaphylactic shock, laryngeal edema, and so on, they cannot be vaccinated against novel coronavirus.

Second, because the infectious disease is in a period of acute fever, it is recommended to postpone the vaccination of novel coronavirus at this stage and control it later.

Third, in the acute attack period of chronic diseases, for example, tumor patients are during chemotherapy, or patients with hypertension are in hypertension crisis, some patients with coronary heart disease are in the attack stage of myocardial infarction, there are some patients with neurological diseases in the progressive stage of the disease, and epilepsy is in the acute attack stage, we suggest that we postpone vaccination against COVID-19 for these patients, and they can also be vaccinated after the condition is stable.

Fourth, vaccination is not recommended because serious or chronic diseases are already at the end of life.

For the elderly, as long as the conditions are met, we must speed up the vaccination of novel coronavirus vaccine, so that we should take it as soon as possible. Only in this way can we better protect our health and life safety.

(front desk reporter Shi Yingchun and Gu Xiaoci)